Corrigendum to “Taiwanese dermatological association consensus statement on management of psoriasis” [Dermatologica Sinica 35 (2017) 66–77](S1027811717300071)(10.1016/j.dsi.2017.01.002)

Tsen Fang Tsai, Chih Hung Lee, Yu Huei Huang, Ching Chi Chi, Yun Ting Chang, Tak-Wah Wong, Chih Hsun Yang, Li Fang Wang

Research output: Contribution to journalComment/debate

Abstract

In page 68, PASI of <0 was incorrect, it is hereby corrected to PASI of <50. The corrected text should read as: Although, currently, PASI 75 (a 75% reduction in PASI) is used to evaluate treatment success, in Taiwan PASI 50 coupled with improved QoL is still acceptable; however, for patients with moderate to severe psoriasis, the doctor should by all means modify the treatment regimen in case of a PASI of <50 regardless of QoL. In Page 69, l100 g was incorrect, it is hereby corrected to 100 g. The corrected text should read as: Use of vitamin D analogues (21/25, 84%) 47, 56–58. Safe upper limit: topical calcipotriol 100 g weekly & topical calcitriol 30 g daily.

Original languageEnglish
Number of pages1
JournalDermatologica Sinica
Volume35
Issue number3
DOIs
Publication statusPublished - 2017 Sep 1

Fingerprint

Psoriasis
Calcitriol
Taiwan
Vitamin D
Therapeutics
corrigendum
calcipotriene

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Tsai, Tsen Fang ; Lee, Chih Hung ; Huang, Yu Huei ; Chi, Ching Chi ; Chang, Yun Ting ; Wong, Tak-Wah ; Yang, Chih Hsun ; Wang, Li Fang. / Corrigendum to “Taiwanese dermatological association consensus statement on management of psoriasis” [Dermatologica Sinica 35 (2017) 66–77](S1027811717300071)(10.1016/j.dsi.2017.01.002). In: Dermatologica Sinica. 2017 ; Vol. 35, No. 3.
@article{c6b8e367c7d748d8b9a12cff225f9df9,
title = "Corrigendum to “Taiwanese dermatological association consensus statement on management of psoriasis” [Dermatologica Sinica 35 (2017) 66–77](S1027811717300071)(10.1016/j.dsi.2017.01.002)",
abstract = "In page 68, PASI of <0 was incorrect, it is hereby corrected to PASI of <50. The corrected text should read as: Although, currently, PASI 75 (a 75{\%} reduction in PASI) is used to evaluate treatment success, in Taiwan PASI 50 coupled with improved QoL is still acceptable; however, for patients with moderate to severe psoriasis, the doctor should by all means modify the treatment regimen in case of a PASI of <50 regardless of QoL. In Page 69, l100 g was incorrect, it is hereby corrected to 100 g. The corrected text should read as: Use of vitamin D analogues (21/25, 84{\%}) 47, 56–58. Safe upper limit: topical calcipotriol 100 g weekly & topical calcitriol 30 g daily.",
author = "Tsai, {Tsen Fang} and Lee, {Chih Hung} and Huang, {Yu Huei} and Chi, {Ching Chi} and Chang, {Yun Ting} and Tak-Wah Wong and Yang, {Chih Hsun} and Wang, {Li Fang}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.dsi.2017.08.002",
language = "English",
volume = "35",
journal = "Dermatologica Sinica",
issn = "1027-8117",
publisher = "Elsevier",
number = "3",

}

Corrigendum to “Taiwanese dermatological association consensus statement on management of psoriasis” [Dermatologica Sinica 35 (2017) 66–77](S1027811717300071)(10.1016/j.dsi.2017.01.002). / Tsai, Tsen Fang; Lee, Chih Hung; Huang, Yu Huei; Chi, Ching Chi; Chang, Yun Ting; Wong, Tak-Wah; Yang, Chih Hsun; Wang, Li Fang.

In: Dermatologica Sinica, Vol. 35, No. 3, 01.09.2017.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Corrigendum to “Taiwanese dermatological association consensus statement on management of psoriasis” [Dermatologica Sinica 35 (2017) 66–77](S1027811717300071)(10.1016/j.dsi.2017.01.002)

AU - Tsai, Tsen Fang

AU - Lee, Chih Hung

AU - Huang, Yu Huei

AU - Chi, Ching Chi

AU - Chang, Yun Ting

AU - Wong, Tak-Wah

AU - Yang, Chih Hsun

AU - Wang, Li Fang

PY - 2017/9/1

Y1 - 2017/9/1

N2 - In page 68, PASI of <0 was incorrect, it is hereby corrected to PASI of <50. The corrected text should read as: Although, currently, PASI 75 (a 75% reduction in PASI) is used to evaluate treatment success, in Taiwan PASI 50 coupled with improved QoL is still acceptable; however, for patients with moderate to severe psoriasis, the doctor should by all means modify the treatment regimen in case of a PASI of <50 regardless of QoL. In Page 69, l100 g was incorrect, it is hereby corrected to 100 g. The corrected text should read as: Use of vitamin D analogues (21/25, 84%) 47, 56–58. Safe upper limit: topical calcipotriol 100 g weekly & topical calcitriol 30 g daily.

AB - In page 68, PASI of <0 was incorrect, it is hereby corrected to PASI of <50. The corrected text should read as: Although, currently, PASI 75 (a 75% reduction in PASI) is used to evaluate treatment success, in Taiwan PASI 50 coupled with improved QoL is still acceptable; however, for patients with moderate to severe psoriasis, the doctor should by all means modify the treatment regimen in case of a PASI of <50 regardless of QoL. In Page 69, l100 g was incorrect, it is hereby corrected to 100 g. The corrected text should read as: Use of vitamin D analogues (21/25, 84%) 47, 56–58. Safe upper limit: topical calcipotriol 100 g weekly & topical calcitriol 30 g daily.

UR - http://www.scopus.com/inward/record.url?scp=85028305001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028305001&partnerID=8YFLogxK

U2 - 10.1016/j.dsi.2017.08.002

DO - 10.1016/j.dsi.2017.08.002

M3 - Comment/debate

AN - SCOPUS:85028305001

VL - 35

JO - Dermatologica Sinica

JF - Dermatologica Sinica

SN - 1027-8117

IS - 3

ER -